Ecofibre Ltd Asset Resilience Ratio
Ecofibre Ltd asset resilience ratio. Ecofibre Ltd (EOF) has an Asset Resilience Ratio of 6.67% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Ecofibre Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Ecofibre Ltd (2017–2024)
Asset resilience ratio of Ecofibre Ltd from 2017 to 2024. This chart shows how Ecofibre Ltd's Asset Resilience Ratio has changed over time. Read Ecofibre Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Ecofibre Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Ecofibre Ltd's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$3.87 Million | 6.67% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$3.87 Million | 6.67% |
Asset Resilience Insights
- Limited Liquidity: Ecofibre Ltd maintains only 6.67% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Ecofibre Ltd Industry Peers by Asset Resilience Ratio
Compare Ecofibre Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Ecofibre Ltd Asset Resilience Ratio by Year (2017–2024)
Ecofibre Ltd asset resilience ratio by year from 2017 to 2024. The table below shows the annual Asset Resilience Ratio data for Ecofibre Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 0.28% | AU$200.00K ≈ $141.51K |
AU$71.25 Million ≈ $50.41 Million |
-0.01pp |
| 2023-06-30 | 0.29% | AU$347.00K ≈ $245.52K |
AU$118.73 Million ≈ $84.01 Million |
-4.69pp |
| 2022-06-30 | 4.99% | AU$7.46 Million ≈ $5.28 Million |
AU$149.55 Million ≈ $105.82 Million |
+1.97pp |
| 2021-06-30 | 3.02% | AU$4.28 Million ≈ $3.03 Million |
AU$141.75 Million ≈ $100.29 Million |
-10.29pp |
| 2020-06-30 | 13.31% | AU$11.22 Million ≈ $7.94 Million |
AU$84.30 Million ≈ $59.64 Million |
-35.74pp |
| 2019-06-30 | 49.05% | AU$23.43 Million ≈ $16.58 Million |
AU$47.77 Million ≈ $33.80 Million |
+24.59pp |
| 2018-06-30 | 24.46% | AU$2.76 Million ≈ $1.95 Million |
AU$11.27 Million ≈ $7.97 Million |
-15.83pp |
| 2017-06-30 | 40.29% | AU$2.45 Million ≈ $1.73 Million |
AU$6.08 Million ≈ $4.30 Million |
-- |
About Ecofibre Ltd
Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer te… Read more